Chronic Coronary Artery Disease: Diagnosis and Management
- Recalibration of a Framingham risk equation for a rural population in India. Chow, C. K.; Joshi, R.; Celermajer, D. S.; Patel, A.; Neal, B. C. // Journal of Epidemiology & Community Health;May2009, Vol. 63 Issue 5, p379
Background: Coronary heart disease (CHD) risk estimation tools are a simple means of identifying those at high risk in a community and hence a potentially cost-effective strategy for CHD prevention in resource-poor countries. Since India has few local data upon which to develop such a tool de...
- Cost-utility analysis of a national project to reduce hypertension in Israel. Yosefy, Chaim; Ginsberg, Gary; Viskoper, Reuven; Dicker, Dror; Gavish, Dov // Cost Effectiveness & Resource Allocation;2007, Vol. 5, p16
Background: This study aims to calculate the health effects and costs of a proposed national hypertension prevention and control program. Methods: Interventions are based on experience from our two programs: 10-year period of Ashkelon Hypertension Detection and Control Program (AHDC Program) and...
- Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation. Stollenwerk, Björn; Gandjour, Afschin; Lüngen, Markus; Siebert, Uwe // European Journal of Health Economics;Dec2013, Vol. 14 Issue 6, p1035
Background: Positive screening results are often associated not only with target-disease-specific but also with non-target-disease-specific mortality. In general, this association is due to joint risk factors. Cost-effectiveness estimates based on decision-analytic models may be biased if this...
- Increased Serum Alkaline Phosphatase and Serum Phosphate as Predictors of Mortality after Stroke. PRATIBHA, S.; PRAVEEN-KUMAR, S.; AGADI, J. B. // Journal of Clinical & Diagnostic Research;Aug2014, Vol. 8 Issue 8, p1
Context: Serum Alkaline phosphatase (ALP) & phosphate are considered to be indicators of vascular calcification. Link between bone metabolism, vascular calcification, cardiovascular events have been well studied in chronic kidney disease and ischemic heart disease. Aims: To determine that...
- Changing mortality from ischaemic heart disease in Great Britain 1968-76. du V Florey, C.; Melia, R.J.W.; Darby, S.C. // British Medical Journal;3/11/1978, Vol. 1 Issue 6113, p635
Reports the increase in mortality rates caused by ischemic heart disease (IHD) in Great Britain. Relation between tobacco consumption and IHD death rates; Influence of diet on the incidence of IHD; Significance of changing life styles in preventing IHD.
- Seasonality of coronary artery deaths in New South Wales, Australia. Weerasinghe, D.P.; MacIntyre, C.R.; Rubin, G.L. // Heart;Jul2002, Vol. 88 Issue 1, p30
Background: Complex temporal variations in coronary deaths, including diurnal, weekly, and seasonal trends, have been reported worldwide. Objective: To describe the magnitude of seasonal changes in coronary artery deaths in New South Wales, Australia. Design: Hospital morbidity data, mortality...
- Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function? // Heart;Sep2002, Vol. 88 Issue 3, p222
Objectives: To examine the generalisability of multivariate risk functions from diverse populations in three contexts: ordering risk, magnitude of relative risks, and estimation of absolute risk. Design: Meta-analysis of prospective cohort studies. Patients: Participants from various...
- Omega-6 linoleic acid supplements may be harmful in heart disease. // Endocrine Today;Mar2013, Vol. 11 Issue 3, p42
The article reports on study published in the "British Medical Journal," which suggests an increased risk for all-cause mortality, cardiovascular death and death related to coronary heart disease for those who suffered a coronary event.
- Let's not take credit for drop in CHD. Smith, Russell; P.F.C. // Cortlandt Forum;4/25/96, Vol. 9 Issue 4, p94
Answers a question concerning reductions in the coronary heart disease (CHD) death rate. Reasons for the decline in mortality rate; Credit for the medical industry.